The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project

Abroad (travel likely)RecruitingPHASE4

Conditions

Dravet Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The University of Texas Health Science Center at Houston, Houston, Texas, United States
Contact: Study coordinator (Samden Lhatoo, MD, FRCP) · Samden.D.Lhatoo@uth.tmc.edu · (713) 500-7106
Contact: Study coordinator (Sandhya Rani) · M.R.Sandhya.Rani@uth.tmc.edu · (713) 500-7499

Study leads

Samden Lhatoo, MD, FRCP
Principal Investigator
The University of Texas Health Science Center, Houston

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age

Dravet Syndrome (DS) · Children Under 2 Years

Abroad (travel likely)RecruitingPHASE4

Aurora, United States

A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

Dravet Syndrome

Abroad (travel likely)RecruitingPHASE3

Phoenix, United States · Little Rock, United States

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Dravet Syndrome

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Little Rock, United States

A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

Dravet Syndrome

Abroad (travel likely)RecruitingPHASE3

Little Rock, United States · Los Angeles, United States